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ABSTRACT 
 
 
Bart, Zachary Ryan. M.S.B.M.E., Purdue University, August 2013. Multi-Scale Analysis 
of Morphology, Mechanics, and Composition of Collagen in Murine Osteogenesis 
Imperfecta. Major Professor: Joseph Wallace. 
 
 
 Osteogenesis imperfecta is a rare congenital disease commonly characterized by 
brittle bones caused by mutations in the genes encoding Type I collagen, the single most 
abundant protein produced by the body. The murine model (oim) exists as a natural 
mutation of this protein, converting its heterotrimeric structure of two Col1a1 molecules 
and a single Col1a2 molecule into homotrimers composed of only the former. This defect 
impacts bone mechanical integrity, greatly weakening their structure. 
 
 Femurs from male wild type (WT), heterozygous (oim/+), and homozygous 
(oim/oim) mice, all at 12 weeks of age, were assessed using assays at multiple length 
scales with minimal sample processing to ensure a near-physiological state. Atomic force 
microscopy (AFM) demonstrated detectable differences in the organization of collagen at 
the nanometer scale that may partially attribute to alterations in material and structural 
behavior obtained through mechanical testing and reference point indentation (RPI). 
Changes in geometric and chemical structure through the use of µ-Computed 
Tomography and Raman spectroscopy respectively indicate a smaller, brittle phenotype 
caused by oim. Changes within the periodic D-spacing of collagen point towards a 
reduced mineral nucleation site, supported by reduced mineral crystallinity, resulting in 
altered material and structural behavior in oim/oim mice. Multi-scale analyses of this 
nature offer much in assessing how molecular changes can compound to create a
degraded, brittle phenotype. 
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1.  OVERVIEW 
 
 
1.1 Hierarchical Structure of Bone 
Bones within the body are complex organ structures that fill several vital 
purposes. Firstly, larger bone structures act as protection for the major vital organs found 
within the torso and the head. The ribcage and the skull protect the lungs, heart, and brain 
from external trauma. Aside from protection, bones provide support and form to the 
remainder of the body. This form allows for various locations within the body to attach 
muscles, allowing locomotion to occur through pulling these lever-like bones within 
major extremities. Apart from mechanics and protection, bones also serve the important 
purpose of manufacturing red blood cells for the body. The mineral composition of bone 
also allows for the storage and distribution of ions used by other body systems, creating 
mineral ion homeostasis. For instance, calcium is an integral molecule for signaling in the 
nervous system. In the case where an individual does not intake enough calcium, the 
body will actually resorb away some of its bone to obtain the calcium ions it needs to 
function properly.  
 
In order to understand bone as a material, it is important to understand that it 
exists as a hierarchical structure. Each level of bone’s organization is affected by the 
arrangement of its smaller constituents, and the different levels are unique from one 
another. At the organ level, each bone in the skeleton has a shape that reflects its purpose. 
The femur and tibia of the leg are long, slender bones that act as levers for movement, 
while the flat, curved bones of the skull form an enclosure to protect the brain. These 
structures are made up of multiple types of bone material that serve different purposes 
within the bones themselves. 
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Considering just one of the long bones, simple radiographs can begin to show 
deeper levels of organization. A breakdown of the hierarchical structure can be seen in 
figure 1.1. Single bones are comprised of two types of tissue structures, cortical and 
cancellous bone. While these types of tissue are composed of the same mineralized 
material, their organizational differences point to their functions. Cancellous, or 
trabecular bone, is found at the end of long bones, and forms as a porous web-like 
structure (80-85% porosity) [1]. This structure acts as a shock-absorber to better cushion 
bones from rigorous activities. This porous region is also where much of red blood cell 
production occurs. This region contains red bone marrow, a tissue rich in hematopoietic 
stem cells that are the precursors to most blood cells. In contrast, cortical, or compact 
bone is a very dense structure. This bone type forms the hard shell of bone that most 
people are more familiar with. This formation provides the primary structural stability of 
the bone and is thus denser (2-5% porosity) than the previously mentioned trabecular 
regions. 
 
 
Figure 1.1: Overall hierarchical structure of bone [2]. It can be seen that at each length 
scale the organizational patterns vary greatly. 
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 While cancellous and cortical bone are made from the same base materials, the 
structure that forms the web and shell arise from different organizational patterns. Mature 
cortical bone is primarily created in what is called an osteon structure. A cross-section of 
an osteon shows a ring-like pattern centered on a single Haversian canal that contains 
blood vessels involved in providing nutrition to cells residing within the mineral matrix 
(Figure 1.2A). These cells, osteocytes, arise as a byproduct of the primary formation and 
remodeling of bone. A portion of bone-forming cells, osteoblasts, become entrapped in 
the mineral matrix and create a connected network of bone cells. Comparatively, 
trabecular packets that form the webbing at the ends of bones (Figure 1.2B) have few 
osteocytes embedded, forming a structure with fewer cells inside the mineralized material 
[3-5].  
 
 
Figure 1.2: Histology of bone types. (A) Toluidine blue stained cross-section of osteon 
structures. (B) Hematoxylin and eosin stained section of single trabeculae. The primary 
difference can be seen with the amount of osteocytes that are embedded in the osteon 
system compared to the trabecular packet. Images courtesy of Joseph Wallace. 
 
 
 Apart from the cellular network contained in the bone structures described above, 
the areas between osteocytes is comprised of the mineralized tissue most commonly 
associated with bone. This mineralized matrix is responsible for creating bone rigidity 
and provides storage for the body’s dietary minerals. This mineralized matrix is also a 
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complex, composite material. Approximately two-thirds of bone’s weight is created by 
inorganic hydroxyapatite, Ca10(PO4)6(OH)2. This mineral forms as a hexagonal crystal, 
roughly 2-3 nm in length, 25 nm in width, and 50 nm in length [6]. While this crystal 
lattice is the ideal form of hydroxyapatite, human diet may cause ions like magnesium, 
strontium, sodium, potassium, and carbonate to substitute for some of the chemical 
structure. The remaining one-third constitutes the organic material found in bone. Of this 
organic material, roughly 10% of it is comprised of other cells, lipids, and growth factors. 
The majority of this organic matter is comprised of a single protein, Type I collagen. 
 
 
1.2 Type I Collagen in Bone 
 Collagen is the single most abundant protein found in the body [7]. All 29 types 
of collagen account for roughly 25-35% of the total protein content in the body, and exist 
as similar proteins with different polypeptide sequences. These proteins have different 
structures. For instance, some are fibrillar in nature, while others are not. Of this content, 
Type I collagen is the most common variety, accounting for 90% of the total collagen 
content [8]. Type I collagen, similar to bone, follows a complex hierarchical structure. At 
the single protein scale, Type I collagen is comprised of a unique heterotrimeric, triple 
helical structure. This right-handed triple helix is created as a combination of two Col1α1 
molecules, and a single Col1α2 molecule. While these two types of molecules are 
different, they share a common repeating amino acid motif [Glycine – X – Y], where 
glycine is repeated every third amino acid in the chain. Glycine plays a key role in 
developing the triple helix structure. As the simplest amino acid, with only a single 
hydrogen as its side-chain, the triple helix forms in such a way that the individual glycine 
molecules fill the vacant space formed by the helical pattern [9]. X and Y represent many 
different amino acids, most commonly proline and hydroxyproline. The difference in this 
X – Y sequence confers the difference between the Colα1 and Colα2 molecules.  
 
 Collagen molecules arrange themselves in a unique way. Some of the earliest X-
Ray diffraction imaging of collagen microfibrils revealed a unique banding pattern 
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associated with Type I collagen [10]. While early images were of poor resolution, it could 
be seen that the banding structure, later called the D-periodicity or D-spacing, had a fixed 
width of approximately 67 nm. Recent studies using more refined imaging techniques 
have confirmed this approximation, but have shown that this banding exists as a 
distribution near this value, with potential alterations linked with disease states [11-13].  
 
 Initially, this banded structure of collagen was not fully understood. Through the 
imaging of single tropocollagen molecule strands [14], it was discovered that a single 
molecule had a length equal to 4.4 times the 67 nm banded repeat distance found in 
aggregated fibrils. This finding implied that there must be some overlap between adjacent 
molecules in this aggregate equal to 0.4 times the repeated distance.  This overlapping 
period then creates a staggered array of molecules in what came to be known as the 
collagen microfibril. Drawing out all the possible arrangements of this staggered array, 
Hodge and Petruska showed that the molecules could not exist in direct contact with 
neighboring molecules in a given row, giving rise to a gap region equal to 0.6 times the 
D-spacing. As larger aggregates form, it can be seen from Figure 1.3 that this gap-overlap 
design will create regions where collagen molecules are aligned/continuous in adjacent 
row, while there is another region where the gaps occur. These differences in 
tropocollagen alignment lead to the banded structure seen in earlier imaging studies. 
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Figure 1.3: Hierarchical development of a collagen fibril. 300 nm long tropocollagen 
molecules form together in a staggered array, ultimately creating a repeated banding 
pattern seen in fibrils measuring 67 nm. This 67 nm distance, D, is formed by 
tropocollagen molecules overlapping a distance equal to 0.4D and a gap region equal to 
0.6D.  
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 While this gap distance was initially defined in the model out of mathematical 
necessity, pores within collagen had been observed in earlier studies [15]. Regardless, 
this 2 dimensional model of a parallel, staggered array of tropocollagen molecules fails to 
explain how a 3 dimensional fibril with a periodic D-spacing structure forms. More 
recent three-dimensional models of collagen based on electron density maps developed 
from X-Ray diffraction data [16] follow this early model very closely. These models 
validated older models of type I collagen in a three-dimensional space. 
 
 Despite being theorized first to justify a model of collagen, a 40 nm gap region 
may play an important role in bone mineralizaiton. Current theories of the mineralization 
process of bone point to these gap regions between tropocollagen molecules serving as an 
origin site for the hydroxyapatite crystal [17]. The 40 nm spacing is serviceably large 
enough to act as a nucleation site for mineralization. The spaces are also filled with the 
telopeptides of collagen molecule strands, creating a negatively charged region [18] that 
further stimulates the nucleation process. This mineral then grows along the collagen 
microfibrils and forms the base composite material that develops into a single layer of 
bone. These single layers of bone then stack in various directions to form a material that 
is resistant to deformation in directions associated with naturally occurring loads. While 
this mineralization process is still debated, the development of mineralized tissue is 
tightly regulated. Alterations to either the organic matrix or the mineral crystals that are 
not repaired by bone remodeling can lead to structural deformities that can damage the 
overall skeletal structure. 
 
 
1.3 Collagen and Skeletal Diseases 
 Since type I collagen is the most common protein in the body, damage to its 
production can produce dire consequences. Similarly, arrested skeletal development can 
greatly damage an individual’s quality of life, or result in premature or prenatal death. 
Many different bone diseases exist, and several find their roots in defective collagen. The 
most commonly known degenerative bone disorder, osteoporosis, leads to an overall drop 
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in bone quality, greatly increasing risk of severe fractures. Other diseases, like scurvy or 
Ehler’s-Danlos syndrome, act on the collagen that creates bone, skin, and cartilage, 
leading to weaker bones and the deformation of other collagen-containing connective 
tissues.   
 
 The most notable of these collagen-affecting diseases is Osteogenesis Imperfecta 
(OI). OI is a genetic disease that affects a portion of either some or both of the Col1α1 
and Col1α2 genes through glycine substitutions or alterations to protein splice sites [19]. 
As a disease, OI has a spectrum of severities. The severity can be based on the location of 
the mutation, or the number of mutations. Mutations located nearer the C-terminus of the 
protein slow the formation of the triple helix, allowing for more post-translational 
modifications the individual protein strands. Additionally, severity is dependent on if one 
or both genes are affected. In the case where only one gene is affected, it is still possible 
for the body to produce normal collagen molecules.  
 
 Typically, OI develops as a genetic modification that causes substitutions of 
glycine molecules with larger amino acids within the tropocollagen molecules [19]. 
Specific variants of the disease denote different symptom levels, but they all manifest 
with some reduction in bone quality or quantity, leading to greatly increased bone 
fracture risk. This has given OI the moniker “brittle bone” disease. Currently, there are 
four main types of the disease, referred to as Sillence classifications [20]. Additional 
classifications five through eight have been added more recently. The four main types 
suffer from additive complications of insufficient collagen quantity and reduced collagen 
quality. Type II OI suffers from both of these collagen deficiencies and is typically fatal 
within the first year after birth. Comparatively, Type I (Quality normal, quantity low) 
patients suffer brittle bones, reduced muscular development, and a blue coloring of sclera 
that is often indicative of this type of OI. In the opposite case, Type III (Quality low, 
quantity normal), patients still experience some of the same symptoms as Type I, but will 
also exhibit severe bone deformation and typically have a much smaller stature. This 
disease is only a mutation of the collagen protein, yet it demonstrates the clear link 
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between the organic and mineral portions of bone. Due to this fact, models of this disease 
offer much in understanding how the organic and inorganic phases of bone interact with 
one another. 
 
 Implications of this disease point to the fact that molecular changes of collagen 
will alter material and structural properties not only of the whole bone, but potentially at 
every length scale. This link has led to several different collagen-deficient animal models 
being developed. For instance, BrtlIV is a mouse model that has been genetically 
engineered to replace a single glycine molecule with a cysteine (G349→C) in the Col1α1 
chain, creating a brittle phenotype [21]. An older model, Mov-13, has one or both Col1α1 
rendered null by genetic insertion [22]. The latter case of Mov-13 is always prenatally 
fatal due to collagen forming from only Colα2 molecules. However, the genetically 
heterozygous Mov-13 animal produces a normal amount of collagen in reduced quality, 
mimicking the effect of Type I OI.  
 
 Apart from genetically engineered model, there is one naturally occurring 
mutation that has been discovered, the osteogenesis imperfecta murine, or oim model. 
Animals of this strain have a random mutation that has inactivated one or both of the 
genes responsible for the creation of the Col1α2 strand of type I collagen [23]. This 
mutation leads to a model of mild to severe type III OI based on the inactivation of one or 
both genes. In the homozygous case, the mouse is incapable of creating proper 
tropocollagen molecules, leading to the creation of Type I collagen solely from α1 
helices. Collagen made in this fashion possess altered structures has shown to be weaker 
[24], create smaller tendons [25], and have a larger intermolecular spacing [26]. The 
heterozygous animal has shown to create a phenotype similar to a less severe state of this 
disease [27].  This disease is not limited to affecting bone and tendon. Any tissue 
containing Type I collagen, like teeth or muscle have also shown reduced mechanical 
ability caused by homotrimer substitutions [28, 29]. Studies contained within this body of 
work are focused on analyzing this oim model of OI.  
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1.4 Analysis Assays 
 Analysis of genetic disease is typically best done at a scale as near the mutation as 
possible. This creates an observation point closer to the root cause of the disease, not 
behind the cascade of complications. It is also important to characterize the phenotype at 
other levels to see how mutations can manifest into higher level alterations. In the case of 
the oim model, a genetic mutation of tropocollagen has influences on all levels of bone 
organization. Due to this fact, this disease model would be best studied at as many 
organizational levels as possible. Techniques described in this section allow for multi-
scale analysis of the oim phenotype to be measured with minimal sample processing. 
Excessive processing, like dehydration or sample powdering is avoided in order to ensure 
that samples are as close to physiological state as possible. Only the first assay described 
in this chapter required polishing and light demineralization of samples to expose 
measurable collagen. All other assays were accomplished using hydrated, unprocessed 
tissues. While this chapter will serve as a brief overview of the techniques, specific 
information of how these techniques were applied can be found in the Materials & 
Methods section. 
 
 The first technique used in this study is atomic force microscopy (AFM). AFM 
imaging provides structural information of collagen at the nano-scale. This technique 
allows for a direct measure of the periodic D-spacing associated with the collagen fibril 
structure. This is done by scanning a sharp probe attached to a silicon cantilever across a 
surface. Differences along the surface topology of collagen fibrils will cause the 
cantilever to deflect. When this deflection is detected by the control system, the stage 
holding the sample is adjusted up or down by piezoelectric transducers some amount to 
restore the cantilever to its “setpoint” position. This movement of the stage is recorded 
and creates a Z-scale intensity image of the collagen surface that can be used to analyze 
the D-spacing of single collagen microfibrils.  
 
 Apart from collagen analysis at the nano-scale, it is also useful to perform 
measures of the mineral phase at small length levels. Raman spectroscopy provides 
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quantitative information on both the mineral and the organic phase of bone. This gives 
information about the nano-structure, but averaged over a micro-scale area. Raman 
spectroscopy is known as a vibrational spectroscopy (Figure 1.4). A single laser is 
focused on the surface of a specimen, with some of the energy penetrating some distance 
into the surface. This energy causes molecular bonds to vibrate, causing a shift in the 
light energy reflected back and measured by the detector of the Raman system. This 
Raman shift is unique to given substances, created by the change in wavelength of the 
reflected light. A general spectrum is not actually created by the content of molecules 
within a compound, but by the bonds between molecules. For instance, the Raman 
spectrum of graphite is inherently different from that of diamond despite both being 
entirely carbon atoms. The Raman spectrum of bone has been studied thoroughly in the 
past [30-32], so changes detected by this technique can be used to identify alteration in 
the material. 
 
Figure 1.4: Schematic of Raman spectroscopy. A laser is shined on a surface, vibrating 
the chemical bonds of the material. In this case, the initial laser (blue) is of a known 
wavelength. There are two possibilities. In the first, the material absorbs some of the 
energy, causing an upward shift (green) of the wavelength. In the second case, the 
vibration of molecules causes the material to release energy, sending back a higher 
energy, lower wavelength (violet). 
 
 
 As technology has developed, new techniques have been created to provide useful 
information in a clinical setting. Reference Point Indentation (RPI) provides information 
similar to what is obtained from traditional mechanical testing with minimal damage 
induced to the structure. RPI uses a dual probe array to assess the material structure. A 
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reference probe is placed on the surface of the bone while an indentation probe is 
extended from inside of the reference probe into the bone. This indentation process is 
cycled a number of times, creating data over a number of cycles. While this process does 
induce some damage to the surface of the bone, damage is only locally isolated to a 100 
µm area [33]. Measures taken from indentation have been linked to material modulus and 
creep behavior. RPI promises clinical relevance. One design of the reference probe (not 
shown in the figure) is that of a hypodermic needle, providing a means to take 
transcutaneous measures of bone [34]. Studies involving RPI with humans have shown 
differences in mechanical behavior with osteoporotic fractures as well as showed RPI’s 
potential as a clinical technique capable of detecting fractures. 
 
 
Figure 1.5: Schematic representation of reference point indentation (RPI). A reference 
probe is lowered into contact with the material in question. After this, a load-sensitive 
probe inside the reference probe is used to indent the surface a number of times to create 
mechanical data. Image courtesy of Max Hammond. 
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 Another common imaging technique used to study bone is microcomputed 
tomography (µCT). In its most basic form, µCT creates three-dimensional images of 
bones through the use of serial X-ray images taken by rotating a sample. More advanced 
µCT systems are capable of measuring the cortical and trabecular structure of bones 
down to the sub-µm level. More information on this technique and its use in studying 
bone can be seen in a review article I have awaiting publication in Advances in 
Computed Tomography entitled “Microcomputed Tomography Applications in Bone and 
Mineral Research.” 
 
 As stated earlier, traditional mechanical testing provides a good deal of useful 
information about the structural and material properties of bone. Three-point bending of 
bones provides material information like elastic modulus and toughness, and structural 
information like stiffness. Both of these types of measures provide useful information. 
Material alterations caused by disease point to an alteration in bone’s constituents, while 
structural weaknesses are convoluted by bone deformation associated with this disease. 
While inherently destructive, three-point bending, as is the case with all previous tests, 
can be done at near physiological conditions if a bone is kept in a hydrated state. The 
main weaknesses associated with these tests are the limitations from the assumptions 
required to utilize small deformation equations. Because of this, interpretation of data 
taken from gross mechanical testing is most reliable at small strains. While these 
equations have some limitations, measures of the plastic deformation region still hold 
useful information in understanding how bone performs under higher load levels.
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2.  INTRODUCTION 
 
 
Bone is a complex material, with levels of structural organization that exist over 
several orders of magnitude in length scale [35]. At the whole bone level, cortical bone 
forms a rigid shell to support the major loading the bone encounters, while trabecular 
webbing at the ends of the bone acts to protect the bone through h its shock-absorbing 
ability [36]. At smaller length scales in cortical bone are osteons, a network of connected 
cells called osteocytes in concentric ring-like structures. Each ring is composed of 
lamellae which, themselves, are built from collagen fibrils seeded with inorganic 
hydroxyapatite crystals. This collagen/mineral composite is the base constituent that 
crafts bone as a tissue and material. Understanding bone from a material standpoint is an 
inherently difficult task. While imaging can provide insight into material architecture and 
organization, this alone is not enough to understand how that material functions at the 
structural level. Mechanical testing can be used to assess the strength of the bone as a 
structure, but it must be coupled with some form of imaging to estimate material 
properties of the bone [37]. Together, these methods are useful for assessing whole bone 
qualities and for estimating tissue level behavior, but they do little to shed light on 
problems which may exist at smaller length scales (i.e. disease induced changes to the 
fundamental constituents of the tissue).  
 
The fundamental constituents of bone, Type I collagen and hydroxyapatite, have 
been well characterized and their composition is well known [26, 38, 39]. Hydroxyapatite 
crystals are created from calcium, phosphate, and hydroxide, with various potential 
substitutions for these ions (e.g. carbonate or fluoride). Collagen fibrils typically do not 
have these types of substitutions. At the molecular level, a single collagen alpha helix has 
a repeating triplet motif of a glycine molecule, followed by two other amino acids. These 
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two others are often proline or hydroxyproline, which causes many to assess collagen 
content by the amount of hydroxyproline [40]. Glycine’s presence as every third amino 
acid is highly important in this structure as well. Since its R-chain is a single hydrogen 
atom, this allows for the glycine to be tucked along the axis of the helix shape made by 
the molecules [9]. These collagen molecules then aggregate to form larger structures, the 
collagen fibril.  
 
Collagen fibrils are made from hundreds of triple helical tropocollagen molecules 
coming together to form a 3 dimensional fibrillar pattern [16]. These heterotrimeric triple 
helices are created as a mixture of two α1 molecules and one α2 molecule. These α chains 
are both created with the same type of repeating structure described above, but are unique 
from one another in their specific amino acid sequence. Differences in the amino acid 
chains, especially molecules like lysine, dictate where cross-linking will occur between 
the α1 and α2 molecules. These triple helices stack upon themselves in a staggered, 
repeating fashion, creating gaps at the end of each tropocollagen molecule within a row. 
Due to this staggered-gap structure (Figure 2.1), there is a repeated pattern where 
tropocollagen molecules overlap adjacent to a region where one tropocollagen gap exists. 
This overlap-gap repeating structure has been shown to have a fixed periodic repeat 
distance, the 67 nm D-periodicity [14]. However, recent studies have shown that this D-
spacing exists as a distribution of values which varies as a function of several disease 
states including osteoporosis [12], Osteogenesis imperfecta [11], and simply in different 
collagen-based tissues[41]. Since collagen and mineral are the basic building materials of 
bone, understanding how they interact to build larger structures is key to assessing bone 
in a material sense.  
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Figure 2.1: The basic formation of collagen fibril structure. The tropocollagen triple helix 
is formed from 2 α1 molecules and 1 α2 molecule to create a heterotrimer structure. 
These tropocollagen molecules stack in a staggered fashion, creating a gap-ridge 
repeating structure. This period associated with this repeating structure is approximately 
67nm [14]. 
 
 
Osteogenesis imperfecta (OI) is a rare congenital disease of collagen wherein the 
triple helix of collagen is compromised due to mutations in either the α1 or α2 collagen 
chains [20]. These mutations lead to defective collagen fibrils in collagen-based tissues 
including bone, skin and dentin [42]. The dominant OI phenotype is in bone and involves 
fracture due to reduced bone quality, leading to the term “brittle bone” disease. A murine 
model (OIM), discovered through random mutations, has a phenotype similar to a mild to 
severe Type III OI in humans [23]. This model is driven by a recessive mutation in the 
gene encoding the α2 chain. In the homozygous case (oim/oim), all Type-I collagen 
molecules and fibrils within the animal are created as homotrimers of α1 chains. These 
homotrimers have different cross-linking of polypeptide molecules [43]. In the case of 
the heterozygous mouse (oim/+), the animal can still produce some measure of normal α2 
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chains. As such, there is a mixture of both normal heterotrimeric molecules as well as 
molecules containing homotrimeric triple helices. A combination of homotrimers and 
heterotrimers are then incorporated into fibrils. This mutation alone has been shown to 
greatly reduce the mechanical properties of bone [27]. 
 
Many studies in oim mice have been performed over the past 20 years, assessing how 
this change in molecular collagen alters higher level properties. These studies have 
shown reduced mineral crystallinity [24] , altered fatigue response [44], reduced bone 
size [45], and more brittle mechanical and structural properties [45, 46]. Further studies 
have attempted to find ways to mitigate the damage done by the disease state [47, 48], 
and how it is affected by common treatments for bone disorders [49, 50]. A limitation of 
previous oim investigations is that most assays are performed at one or two discrete 
length scale. As bone is a composite material with varying organization at each level of 
the structural hierarchy, it is important to approach the analysis of bone at multiple levels 
ranging from the nanoscale to the whole bone to understand how nanoscale changes 
impact each level of organization. Furthermore, maintaining samples as close to a 
physiological state as possible through hydration and minimal processing is important to 
minimize artifacts that can arise during processing (i.e. dehydration, embedding, etc.). 
The goal of this study was to perform a multi-scale phenotypic analysis of bone from 
heterozygous and homozygous oim mice, maintaining samples as close to physiological 
conditions as possible. It was hypothesized that the underlying issue associated with this 
disease is linked to a problem with the ability to properly form and organize the collagen 
matrix. This alteration of the organic matrix may impact the formation and performance
of the inorganic phase of bone. 
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3. MATERIALS AND METHODS 
 
 
3.1 Animals 
Animals were obtained from The Jackson Laboratory at approximately 12 weeks 
of age. All animal handling was done with prior IACUC approval (protocol number 
SC197R).Thirty-five female mice from 3 groups were utilized: homozygous; B6C3Fe 
a/a-Col1a2
oim
/Col1a2
oim 
(oim/oim, n = 11), heterozygous; B6C3Fe a/a=Col1a2
oim
/J 
(oim/+, n = 9), and wild type control; B6C3FeF1/J a/a (WT, n = 15). Sample sizes 
between groups were different due to in vivo fractures and/or deaths in the oim/oim group 
caused by the disease state, as well as shipping errors resulting in a portion of the oim/+ 
group arriving at 13 weeks of age. Upon arrival at 12 weeks of age, animals were 
sacrificed via CO2 inhalation, at which time animals were weighed, and then femora were 
harvested, stripped of soft tissue and stored wrapped in phosphate buffered saline (PBS) 
soaked gauze at -20 °C.  
 
 
3.2 Atomic Force Microscopy (AFM) 
Right femora (n = 5 per group) were processed and imaged using atomic force 
microscopy (AFM) as previously described [13]. Each bone had distal and proximal ends 
removed with a low-speed sectioning saw. Bones were then mounted to a steel disk with 
anterior side facing up, using cyanoacrylate glue. A flat surface along the anterior side 
was created using a 3 µm water-based diamond suspension. Bones were sonicated for 15 
sec to remove any residue from the polishing process. In order to expose collagen, bones 
were demineralized using 0.5 M EDTA at a pH of 8.0 for 15 minutes, and then sonicated 
for 5 minutes in ultrapure water to liberate unbound mineral crystals and ions from the 
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surface. This process was repeated a total of three times to create a surface suitable for 
AFM imaging.  
 
Samples were imaged in air using a Bioscope Catalyst AFM (Bruker, Tucson, 
AZ). Images were taken in peak force tapping mode using silicon probes on silicon 
nitride cantilevers (Scanasyst-Fluid+; Bruker, Camarillo, CA) at a scanning rate of 0.5 Hz 
at 512 lines of resolution for each image. Three to four 25 µm x 25 µm regions were 
selected along the length of each bone. Areas for fibril analysis were further examined at 
10 x 10 µm to search for usable fibril groups. Two to three images at 3.5 x 3.5 µm were 
acquired at each location, and 10-25 individual fibrils were analyzed. In total, an average 
of 55 fibrils was measured in each bone. D-spacing of individual collagen fibrils was 
determined from the power spectrum of a 2D Fast Fourier transform as previously 
described [11, 13, 51] (SPIP Version 5.1.10, Image Metrology, Denmark). All 
measurements within a single bone were averaged to produce a single measure from each 
bone for group comparisons (n = 5 per group). In addition, all individual fibril 
measurements were used for population comparisons (n = 254-289 per group). 
 
 
3.3 Raman Spectroscopy 
Raman spectroscopy was performed using a LabRAM HR 800 Raman 
Spectrometer (HORIBA Jobin Yvon, Edison, NJ) connected to a BX41 microscope 
(Olympus, Tokyo, Japan).  A 660 nm laser was focused on the sample surface using a 
50X objective to a spot size of ~10 μm. Five locations approximately 1 mm apart along 
the posterior surface of fresh, unprocessed right femora were placed in a PBS bath with 
PBS surrounding the bone but not covering the posterior surface. Five 20 sec acquisitions 
were averaged at each location and baseline corrected to create a single measure at each 
location (LabSpec 5, HORIBA Jobin Yvon). Using OriginPro 8.6 (OriginLab, 
Northampton, MA), a single Gaussian peak was fit to the PO4
3-
 ν1 peak. Areas under the 
PO4
3-
 ν1, CO3
2-
 ν1, Amide III, CH2 wag, and Amide I peaks were calculated at each 
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location. All locations were pooled into a single measurement from each bone for group 
comparisons (n = 5-6 per group).   
 
 
Figure 3.1: A typical Raman spectroscopy spectrum for a single location. Values have 
been normalized to the maximum value obtained from the scan. Crystallinity is calculated 
as 1/full width at half maxima (FWHM) of the phosphate peak. Values of PO4
3-
, CO3
3-
, 
Amide III, CH2, and Amide I were calculated via curve fitting of the surrounding Raman 
spectra. 
 
 
Type B carbonate substitution levels were calculated from the band area ratio of 
CO3
2-
 ν1/ PO4
3-
 ν1. The degree of matrix mineralization was determined using three 
distinct band area ratios: PO4
3-
 ν1/Amide I, PO4
3-
 ν1/ CH2 wag, and PO4
3-
 ν1/Amide III. 
The ratio of Amide I/Amide III was also calculated to measure changes which may have 
occurred under the Amide I peak. Crystallinity/maturity was determined by 1/full width 
at half maxima (FWHM) of the PO4
3-
 ν1 peak (Figure 3.1). 
 
 
3.4 Reference Point Indentation 
Following Raman spectroscopy, the same femora were tested using a BioDent 
Reference Point Indentation (RPI) system (Active Life Scientific, Santa Barbara, CA). 
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Four indentations (BP3 BioDent probe assembly) were made along the length of the 
posterior surface of each femur, chosen to be in the same region as four of the five 
Raman measurements (limited to 4 locations due to orientation restrictions with the 
BioDent sample fixture). Cyclic indentation was performed in load control to 2 N for 5 
loading cycles. The indentation probe creates an indent that is approximately 100 µm in 
diameter [34], allowing for sufficient space between each measurement without 
interaction with damage induced from previous indents. All bones were hydrated with 
PBS throughout indentation. Measurements from RPI were calculated using a custom 
MATLAB script which allows for cycle-by-cycle analysis [52]. Calculated parameters 
included indentation distance (ID), indentation distance increase (IDI), total indentation 
distance (TID), creep indentation distance (CID), energy dissipation, and unloading 
slope, all taken from averaging the values measured in cycles 2-5. Measurements from 
the four locations in each bone were averaged to produce a single value for each measure 
in each bone. 
 
 
3.5 Micro Computed Tomography (µCT) 
Ex vivo scans of left femora were performed using a Skyscan 1172 high-
resolution µCT (Bruker-MicroCT, Kontich, Belgium). Prior to scans, the overall length 
of each bone was measured and the bones were inspected for any apparent in vivo 
fractures. Calibration was performed daily using two cylindrical hydroxyapatite 
phantoms (0.25 and 0.75 g/cm
3
 CaHA) and a water sample. Scans were performed at an 
isotropic voxel size of 11.93 µm resolution (V = 50 kV, I = 167 µA).  
 
Femoral geometric properties were measured from 7 slices centered at the 
midshaft. Volumetric bone mineral density (BMD) measures were made at five standard 
sites spaced 2mm apart taken from the posterior quadrant of bone from µCT images to 
complement measures obtained through Raman spectroscopy. Binary images were then 
created from these standard sites with a standard threshold set for determining calcified 
tissue. Standard site geometric information was analyzed using a MATLAB image 
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analysis processing script [53]. Trabecular analysis in the distal femur was accomplished 
by setting a cylindrical cross section inside the cortical shell of the bone. A circular face 
was created just touching the distal growth plate and was then extended to 0.5 mm in the 
proximal direction to create a volume enclosing the trabecular envelope. A ratio of bone 
volume to tissue volume (BV/TV) was calculated to assess the trabecular organization 
within the bone. Additionally, trabeculae in this region were measured for the average 
thickness of individual struts and the separation between these structures.  
 
 
3.6 Whole Bone Mechanical Testing 
Following µCT, left femora were monotonically tested to failure in displacement 
control at a loading rate of 0.3 mm/sec in 3-point bending (Test Resources, Model 
100R500-12, Shakopee, MN). The apparatus had a support span of 5 mm. Femora were 
aligned such that the loading point was in contact with the anterior surface of the bone at 
the mid-diaphysis, testing in the anterior-posterior (AP) direction (posterior surface in 
tension). Force and displacement were measured during each test at 30 Hz. Following 
fracture, the fracture location was measured relative to the proximal end of the bone 
using digital calipers (accurate to 0.01 mm, Marathon, Richmond Hill, Ontario). A subset 
of geometric properties at the fracture location were obtained from µCT data and were 
used to convert force and displacement to stress and strain using standard beam bending 
equations [54]. 
 
 
3.7 Statistical Analysis 
With the exception of nanoscale morphology (mean ± standard deviation), all data 
are presented as mean ± standard error. Statistical analysis was performed using one-Way 
ANOVA (non-parametric Kruskal-Wallis tests, or two-sample T-tests of unequal 
variance with Bonferroni correction when appropriate) with pairwise Tukey and Dunn’s 
post hoc tests (SigmaPlot, Jandel Scientific). Measurements lacking homoscedasticity 
between groups were transformed prior to comparison and then analyzed with 
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appropriate tests. Kolmogorov-Smirnov tests were performed to assess population 
differences in collagen fibril D-spacing distributions as previously described [11, 13]. In 
all cases, a value of p< 0.05 was considered significant.   
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4. RESULTS 
 
 
4.1 Nanoscale Morphology: Atomic Force Microscopy 
To assess the nanoscale morphology of Type I collagen fibrils, the D-periodic 
spacing of individual fibrils was measured in bone from WT, oim/+ and oim/oim mice. 
Images were acquired from 3-4 locations in each of 5 bones per animal. 2D Fast Fourier 
Transforms were performed on 10-25 individual fibrils at each location. Measurements 
from each bone were averaged to yield the mean fibril spacing for that bone, then the 
WT, oim/+ and oim/oim values were compared (Figure 4.1).  D-spacing in the oim/+ 
(65.6±0.1 nm) and oim/oim (65.4±0.5 nm) were both significantly lower than WT
(66.0±0.2 nm), but were not significantly different from each other. 
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Figure 4.1: Entire distribution of fibrils measured for D-spacing through AFM analysis. 
While the distribution of all fibers is wide, statistical analysis was done on averages taken 
for each bone. Non-parametric statistical tests showed WT bones to have higher average 
fibril D-spacing (p < 0.05) than both oim/+ and oim/oim. 
 
 
Figure 4.2A shows that a distribution of D-period spacings existed in each group. 
To define a main population of fibrils within each group, fibrils included within the mean 
± 1 standard deviation of the entire WT population (289 fibrils) were used. Within this 
range, 71.3% of WT fibrils, 73.5% of oim/+ fibrils and 63.0% of oim/oim fibrils were 
found. Below this range, 13.8% of WT fibrils were found in comparison to 18.9% for 
oim/+ and 28% for oim/oim, indicating that the population distribution in the 2 disease 
states was shifted downwards versus WT. Kolmogorov-Smirnov tests of fibril 
populations showed all groups to be distributed differently from one another (Figure 
4.2B).  
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Figure 6.2: Fibril analysis of all fibrils measured. Panel A shows a histogram of fibrils in 
each group, demonstrating the distributions of all fibrils. Panel B is a cumulative 
distribution function (CDF) of fibrils depicting differences in the population distributions
 as indicated by Kolmogorov-Smirnov tests. 
 
 
4.2 Raman Spectroscopy and Volumetric Bone Mineral Density (vBMD) 
The mineral to matrix ratio (MMR) can be measured in several ways, by 
normalizing the phosphate 1 peak to one of several peaks related to collagen (Table 1). 
For all three measures of MMR used here, the only significant difference was a decrease 
in MMR Amide I in oim/oim relative to WT. A significant increase in the Amide 
I:Amide III case in oim/oim versus WT suggests that there is a significant change in the 
Amide I peak in the oim/oim group.  In terms of mineral composition, there was no 
difference in the carbonate:phosphate ratio between any groups, but there was a 
significant decrease in crystallinity in oim/oim versus WT and oim/+. Volumetric bone 
mineral density (vBMD) was also assessed via µCT analysis. Similar to the Raman MMR 
data, vBMD was lowest in the oim/oim genotype, but only significantly lower than the 
oim/+ due to the higher error associated with the oim/oim values. 
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Table 4.1: Assessment of chemical properties obtained via Raman Spectroscopy 
 WT(n = 6) oim/+ (n = 6) oim/oim (n = 5) 
MMR Amide I 2.541±0.125
 
2.3462±0.128 1.9242±0.056
a 
MMR CH2 4.344±0.230 4.0673±0.653 3.7616±0.109 
MMR Amide III 3.769±0.259 3.7444±0.218 3.4385±0.097 
Amide I:Amide III 1.502±0.048
 
1.6247±0.044
 
1.7971±0.056
a 
Carbonate:Phosphate 0.503±0.013 0.4997±0.008 0.4990±0.019 
Crystallinity 0.054±0.0003
 
0.0534±0.0001 0.0519±0.0001
a,b 
Volumetric Bone Mineral 
Density (g/cm
3
)* 
1.576±0.009
 
1.591±0.012
 
1.540±0.024
b 
aSignificantly different from WT data at α = 0.05. 
bSignificantly different from oim/+ data at α = 0.05. 
* Volumetric bone mineral density (vBMD) measured at five posterior sections along the 
diaphysis via µCT. 
 
 
4.3 Reference Point Indentation 
Reported values of ID, IDI, CID, and energy dissipation (Table 2) are all 
measurements related to the accumulation of microdamage induced by cycling the 
indentation probe [55]. Trends in treatment levels are similar across these variables with 
increased values in the oim/oim versus WT without an increase in the oim/+ values. With 
the exception of a significant increase in ID for oim/oim versus both WT and oim/+, no 
other differences reached statistical significance. Unloading slope is a measure stiffness 
of a sample, similar to elastic modulus. RPI data suggests no difference in oim/+ versus 
WT, but a significantly lower value for unloading slope in oim/oim mice versus WT and 
oim/+.  
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Table 4.2: Measurements obtained from reference point indentation system 
 WT (n = 6) oim/+ (n = 6) oim/oim (n = 5) 
ID (µm) 9.566±0.307 9.329±0.255
 
12.528±1.033
a,b 
IDI (µm) 3.912±0.748 3.833±0.280 4.6056±0.911 
TID (µm) 31.653±1.070 31.210±1.003 35.291±1.774 
CID (µm) 1.184±0.108 1.143±0.068 1.364±0.236 
Energy Dissipation (µJ) 4.601±0.480 4.768±0.203 5.283±0.867 
Unloading Slope (N/µm) 0.267±0.007 0.271±0.009
 
0.211±0.009
a,b 
Values presented as the mean ± standard error with all locations in a bone pooled into one 
measurement 
a
Significantly different from WT data at α = 0.05. 
bSignificantly different from oim/+ data at α = 0.05. 
 
 
4.4 Micro Computed Tomography 
Severe alterations in bone morphology are typical of the oim model [23]. Figure 
4.3 shows schematics of the average cross-section of the femoral mid-diaphysis from 
each group (data appear in Table 3). Apparent from the images is the significantly 
reduced total cross sectional area and cortical area in the diseased genotypes. There were 
also significant decreases in both cortical area and cortical thickness for both disease 
states. Less apparent is the significantly larger marrow cavity in the WT versus oim/+ and 
oim/oim. In agreement with other changes, both periosteal and endocortical surface 
perimeters were decreased in oim/oim relative to WT. 
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Figure 4.3: Average profiles of oim/+ and oim/oim animal overlaid on the WT average 
cross-section.  
 
 
 
Table 4.3: Standard site measurements of femur cortical geometry 
 WT (n = 15) oim/+ (n = 9) oim/oim (n = 8-9) 
Cross-Sectional Area 
(mm
2
) 
1.219±0.019
 
1.054±0.045
a 
0.745±0.032
a,b 
Cortical Area (mm
2
) 1.144±0.036
 
0.980±0.040
a 
0.632±0.025
a,b 
Marrow Area (mm
2
) 0.858±0.023
 
0.733±0.044
a 
0.733±0.057
a 
Cortical Thickness (mm) 0.274±0.004
 
0.254±0.009
a 
0.178±0.008
a,b 
Periosteal Surface (mm) 5.900±0.046
 
5.568±0.087
 
5.000±0.125
a,b 
Endosteal Surface (mm) 4.100±0.062
 
3.792±0.103 3.789±0.193
a 
a
Significantly different from WT data at α = 0.05. 
bSignificantly different from oim/+ data at α = 0.05. 
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Trabecular analysis of the distal femur (Figure 4.4) showed a significant decrease 
in BV/TV with increasing disease severity. Similarly, the average thickness of these 
trabeculae was significantly decreased in both oim/+ and oim/oim versus WT. The 
separation between trabeculae was significantly higher in oim/oim versus WT and oim/+, 
lending to its reduced BV/TV. 
 
 
Figure 4.4: Analysis of trabecular structure of distal femur. (A) Trabecular density 
measure of BV/TV. (B) Average thickness of trabecular webbing. (C) Average separation 
between individual trabeculae. Data show a significant loss in trabecular amount within 
the femoral metaphysis.  (D-F) Representative sagittal cross-sections of WT, oim/+, and 
oim/oim femora, showing the degenerated trabecular structure. 
 
 
4.5 Whole Bone Mechanical Testing – 3 Point Bending 
Left femurs underwent three-point bending to failure. Stiffness (Table 4) had a 
significant trend downwards with disease severity, with oim/oim demonstrating a 
significant drop from the other two. Yield force was significantly different between all 
groups, decreasing from WT to oim/+ and further to oim/oim. Ultimate force showed a 
similar decreasing trend across groups, but only the oim/oim group differed from WT and 
oim/+.  Yield displacement showed an increase in the oim/oim vs oim/+, but not between 
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other groups. Post-yield displacement had a significant downward trend in the disease 
states, and both work to yield and failure were significantly reduced in both oim/+ and 
oim/oim versus WT. Post-yield work showed significant drops with each disease state.  
 
Table 4.4: Additional structural data obtained from three-point bending of left femora. 
 WT oim/+ oim/oim 
Stiffness (N/mm) 181.176±7.489 175.280±8.840 69.966±8.402
a,b 
Yield Force (N) 18.539±0.553 14.334±1.329
a 
8.189±0.736
a,b 
Failure Force (N) 24.205±1.216 19.877±8.131 9.382±0.845
a,b 
Yield Displacement 
(µm) 
118.318±4.628 99.057±10.861 136.583±7.558
b 
Postyield Displacement 
(µm) 
391.960±19.821 201.587±24.718
a 
60.254±26.924
a,b 
Yield Work (mJ) 1.088±0.047 0.769±0.123
a 
0.538±0.047
a 
Postyield Work (mJ) 10.090±0.510 3.859±0.5429
a 
0.574±0.297
a,b 
aSignificantly different from WT data at α = 0.05. 
bSignificantly different from oim/+ data at α = 0.05. 
 
 
At the tissue level (Figure 4.5), yield stress was marginally changed amongst 
groups (p = 0.069), but ultimate stress was significantly lower in oim/oim versus both 
WT and oim/+. Oim/+ bones had lower yield strain versus WT, but the brittle nature of 
the diseased bones became apparent with the significant decrease in total strain for both 
oim/+ and oim/oim versus WT, and a drop from oim/+ to oim/oim. Modulus was 
significantly greater in oim/+ versus both WT and oim/oim but was not significantly 
different between WT and oim/oim despite a 16% decrease. The oim/oim bones had 
significantly lower resilience compared to WT, showing a decreased ability of the tissue 
to elastically store energy. A significant decrease in total toughness between both oim/+ 
and oim/oim with WT, and a decrease in oim/oim versus oim/+ further indicates a lack of 
post-yield behavior worsening with disease severity. 
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5. DISCUSSION 
 
 
As a genetic disease model that alters collagen formation, analyses in oim bone 
requires studying nanoscale features to understand how a molecular change in collagen 
can alter material and structural-level properties in bone and change the development of 
the skeletal system as a whole. The images in Figures 4.3 and 4.4 illustrate how drastic 
these changes can be when they propagate up to alter whole bone structure. Ideally, 
through an assortment of experiments at multiple length scales, it should be possible to 
find a link between the weakened structure and the base material of bone as fabricated in 
the body (i.e. collagen fibrils and mineral crystals). Testing at different length scale 
provides insight into how changes in tropocollagen processing and formation lead to 
alterations in morphology, tissue chemistry and material mechanical properties. 
Techniques used in this study maintained hydration within the bone, preventing 
degradation of mechanical integrity prior to mechanical tests [56]. Additional tests could 
then be performed on the same samples, as most tests were non-destructive. Damage 
created by surface indentation tests is limited to local microcracks, allowing for 
topographic measures of other regions of the bone.  
 
Measurements of D-spacing obtained from AFM measurements provide structural 
information of collagen at the nanoscale. Mean differences in D-spacing between groups 
are not typical in disease states as distributions can be wide and sample numbers are 
typically small [12]. In this study, there was a quantifiable decrease in D-spacing which 
became more pronounced with disease severity. This difference is likely driven by an 
increase in the average length of tropocollagen molecules in the homotrimeric state [57] , 
causing a decreased end-to-end spacing which in turn decreases the D-spacing of the 
fibril. The decrease noted here is important because this alteration in collagen fibril 
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structure could have implications on the size of mineral nucleation sites [58], indicating 
that a change in the organic portion of bone is directly driving alterations in the inorganic 
phase. The D-spacing distribution is more often used to probe disease-induced 
differences and has been sensitive enough to detect differences due to osteoporosis in 
skin [51] and bone [12, 59], and osteogenesis imperfecta in bone and tendon [11, 13]. 
While a mean difference was present between the oim/oim mice and both other groups, 
important insight into this difference comes when examining the CDF. Here the oim/oim 
population shape is similar to WT, but is shifted downward towards lower spacing 
values. This shift is driven by the fact that 28% of the oim/oim population of fibrils fall 
outside the mean ±1 standard deviation of the WT group. Interestingly, the lower end of 
the CDF for the oim/+ group closely follows the WT distribution while at the higher end 
it is more similar to the oim/oim group. This trend is driven by the jump in fibrils in the 
oim/+ group with spacings near 66 nm. The difference in distributions indicates that the 
oim/+ population is an intermediate disease state [27]. Because of the nature of this 
mutation, all fibrils in the oim/oim group are composed of 100% 1 homotrimers since 
the animals cannot produce 2 chains. Oim/+ mice have the ability to produce normal 2 
chains, meaning that some tropocollagen molecules are 1 homotrimers and some are 
normal heterotrimers. These are then randomly incorporated into fibrils as they form. The 
data indicate that some of these fibrils have similarities to normal collagen fibrils from 
WT mice while others are more characteristic of homotrimers. This observation has 
important ramifications to the interpretation of mechanical integrity in these bones. 
 
Structural differences between the homotrimer and heterotrimer are likely driving 
a loss of collagen strength in oim/+ and oim/oim bone. While both α1 and α2 chains 
possess a Gly-X-Y amino acid repeating structure, the amino acids present in the X-Y 
positions differ [60]. Hydroxylation of both proline and lysine allows for hydrogen 
bonding between chains in heterotrimeric molecules [61]. Heterotrimers are aligned in 
such a way for these bonds to form readily due to the difference in structure between the 
α1 and α2 molecule primary structure. Additionally, collagen molecules form both inter- 
and intramolecular cross-links through both enzymatic, and nonenzymatic processes. 
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Enzymatic cross-linking, catalyzed by lysyl oxidase (LOX), link collagen together 
through the recognition of unique binding sites on the collagen structure [62]. The 
difference in the homotrimer structure leads to a different secondary structure, altering 
binding sites that may lower LOX activity or reduce hydrogen bonding between 
molecules. Previous studies have shown that there is an increase in the intermolecular 
distance in homotrimeric structures, causing a reduction in the ability to cross-link in the 
oim state [43].  Modelling has shown that the amount of cross-linking between collagen 
molecules plays a key role in the ability to resist deformation [63]. Loss of these key 
binding structures may reduce the strength of the organic phase in bone. 
 
The interaction of the organic and inorganic phase of bone also determines 
material properties. Raman spectra of bone generally infer the same base chemical 
structure given different disease states, but shifts expressed in various peaks give some 
indication as to how the structure has changed [32]. Differences in genotypes are often 
seen as alterations within the composition of collagen molecules, resulting in altered 
material composition of the bone. Altered composition in bone is most apparent through 
changes in the ratio of organic to inorganic components, or alterations in the crystal size, 
structure, and perfection. Reduced crystallinity in oim/oim bone has been shown through 
X-ray diffraction in previous studies [24], and is seen in Raman spectroscopic analyses in 
the current study.  A reduction in crystallinity suggests a defect in the binding and growth 
of mineral crystals within bone [64]. While vBMD is often a predictor of material 
modulus [65], the lack of significance in mean vBMD between WT and oim/+ does not 
explain the significant increase in material modulus in oim/+ bone. Considering typical 
crystalline materials, like ceramics, crystal size plays a factor in the modulus of the 
material. Crystal size dictates the level of surface interactions between crystals within the 
ceramic, i.e. the more surface interactions, the stronger the material [66, 67]. Marginally 
reduced crystallinity in the oim/+ with vBMD near WT levels may explain the increase of 
material modulus seen with the mild disease. While the crystallinity is significantly lower 
in the oim/oim, the significant drop in vBMD indicates fewer, smaller crystals to support 
the structure and likely led to the drop in modulus in oim/oim versus oim/+.  
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Whole bone mechanical testing data indicate that oim/+ bones have the highest 
material modulus. This result may seem counterintuitive, as oim/+ is a milder form of the 
disease state [27], but as shown above, oim/+ benefits from a higher vBMD and smaller 
crystals to better resist elastic deformation. Lowered resilience and modulus in the 
oim/oim indicates degraded elastic behaviour of the material. The brittle nature of the 
mutated groups can be seen in their lack of post-yield deformation, total deformation, 
total strain and toughness. These properties are all indicative of the ability of a material 
and structure to deform and absorb energy without failing and all were decreased in the 
oim/+ group and further decreased in the oim/oim group versus WT (Figure 4.5). 
Deficiencies in toughness and postyield displacement indicate that a material and 
structure is brittle, failing with little plastic deformation. Typically, it is thought that 
elastic response of bone is driven by mineral while plastic deformation is dominated by 
the organic phase of the bone [68]. Changes in both preyield and postyield behavior 
would indicate that the genetic alteration in collagen is influencing both the organic and 
inorganic phases of the material.  
 
The degraded mineral-matrix structure in oim/oim directly leads to the brittle 
nature of bone in this animal model which caused significant sample loss here and 
elsewhere due to premature animal death or in vivo fractures [69]. The MMR Amide I 
appears to indicate a large significant decrease in mineral content for oim/oim bone, but 
this observation is likely not true. The Amide III band is resistant to alterations from 
disease states [70], and can be considered constant across all groups here. The significant 
change noted here in the ratio of Amide I:Amide III suggests a significant alteration in 
the Amide I band in the two disease states. This observation suggests that the collagen 
matrix has been altered since the Amide I band is indicative of the secondary structure of 
collagen [71]. This change in secondary structure can also be detected by the changes in 
D-spacing distributions noted above. Since the MMR Amide I is the only marker for 
mineral content that was changed versus WT, this significance is driven by altered 
collagen, and the other measures of mineralization are more indicative of the actual 
mineral content. Post-hoc statistical power analysis of Raman  MMR measures revealed 
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slightly lower power levels (P = 0.4-0.5), and these smaller changes may become 
significantly detectable by increasing Raman sample sizes to 9+ animals to achieve 
higher power. Importantly, many other studies have used the Amide I band to measure 
MMR [72, 73]. Data here supports the notion that the MMR Amide I band should be used 
with caution [70]. 
 
Bone as a structure is a complex hierarchy of composite-like mineralized 
collagen. Organization varies at small length scales due to the directional organization of 
collagen, but at larger length scales, much is determined by the organization and 
thickness of trabeculae and cortical bone. Mineral crystallization occurs at a much 
smaller length scale [74] when compared to the area of material tested using RPI testing 
or bending [33]. Because of this size difference, it is safe to assume that the same 
hierarchical level of material is being tested in RPI and bending. It is not surprising that 
the trend in stiffness measured from micro-scale indentation tests were mirrored by 
material trends obtained from whole bone mechanical testing. RPI is a new technology 
that is capable of obtaining clinically-relevant micro-scale mechanical data while 
minimizing the structural damage induced to the specimen [34, 75]. Because of this, the 
unloading slope obtained from RPI testing can be used to show differences in bone 
modulus without inducing major damage to the structure, preserving the remainder of the 
bone for testing using other techniques. The increasing trend of indentation stiffness was 
not significant. IDI for oim/oim was 30% higher than WT, but had a considerably higher 
variance, preventing significance from being reached as well. A lack of significant 
differences in these measures is likely due to lack of power in the test, which could be 
remedied by increasing sample sizes in future studies.  
 
According to Wolff’s law, bone structures will adapt to the forces that the bone 
experiences [76]. The material deficiencies of both the organic and inorganic phases that 
arise from the oim model reduce the ability of bone to resist fracture, resulting in a 
biological adaptation to alter the bone’s structure in an attempt to compensate. Previous 
studies have shown an increase in bone turnover within these disease states [77]. This 
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effect is likely a cellular response attempting to remove the malformed collagen matrix. It 
is possible that the increased cellular response is selectively remodeling areas that are 
rich in homotrimeric collagen. This observation could account for the recovery of 
material properties that have been observed over time in the oim/+ animal model [78, 79]. 
Future studies are planned to look at the progression of the oim/+ and oim/oim 
phenotypes with aging using the current multiscale approaches. In addition, cellular
aspects of these phenotypes will also be interrogated. 
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6. CONCLUSIONS AND FUTURE DIRECTIONS 
 
 
Many techniques exist to assess the structural, material and chemical properties of 
bone. Often, the processing necessary to create samples for these techniques is harsh, 
limiting the useful and relevant data that can be acquired. Histology and X-ray diffraction 
both provide valuable information about bone composition. However, histology requires 
embedding, demineralization, and sectioning, while X-ray diffraction requires the sample 
to be powdered to assess information about the mineral [80, 81]. Additionally, techniques 
like transmission electron microscopy or scanning electron microscopy provide equally 
useful data, but suffer from as harsh sample preparation, including thin sectioning, 
dehydration, and gold coatings [82, 83]. Assays used in the current study maintained the 
bone in as close to its native state as possible. Raman Spectroscopy and RPI testing were 
both done on the surface of unprocessed bones resting in a PBS bath. All mechanical 
testing was done with continuous hydration of samples. The harshest processing required 
in the current study was that used to image the bone using AFM. This technique requires 
a modest amount of demineralization of the bone’s surface to expose the underlying 
collagen. The net result here is that each of the techniques used provide measures as near 
to a physiological states as possible. 
 
Overall, this study demonstrates how molecular changes to collagen due to a genetic 
defect can drastically alter properties throughout the tissue hierarchy in both the organic 
and inorganic portions of bone. Alterations to the collagen triple helix modify the 
assembly of collagen fibrils. We postulate that the fibrillar defect detected by AFM 
changes how hydroxyapatite crystals are able to bind and grow in this altered matrix 
material. Changes in the collagen/mineral composite impact the mechanical properties of 
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the tissue and ultimately, at the highest levels of organization, the presence of 
tropocollagen homotrimers creates significantly weaker bone. Future studies will be 
aimed at assessing nonmineralized tissues to look for similar shifts in periodic D-spacing 
as well as changes in fibrillar width. These studies will allow for a direct analysis of 
collagen without the convoluting influence of mineral. Additional studies will be 
performed to directly assess the molecular cross-linking that occurs in the defective 
homotrimeric structure. 
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